JENNIFER MCFADDEN: Open Payments
NPI 1871708651 · DOYLESTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 16 payments from 8 companies in 2025. Trend: 2023 $440 · 2024 $410 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $104 |
| Incyte Corporation | 3 | $87 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Botanix SB Inc | 2 | $52 |
| ABBVIE INC. | 3 | $49 |
| LifeNet Health | 1 | $44 |
| Amgen Inc. | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $18 |
Products named: DUPIXENT, OPZELURA, SOFDRA, SKYRIZI, TheraGenesis Wound Matrix, OTEZLA, COSENTYX, TREMFYA.
Industry payments across PA — which companies pay providers there.
